摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

piperidin-4-yl(pyridin-3-yl)methanone | 747403-13-0

中文名称
——
中文别名
——
英文名称
piperidin-4-yl(pyridin-3-yl)methanone
英文别名
piperidin-4-yl-pyridin-3-yl-methanone
piperidin-4-yl(pyridin-3-yl)methanone化学式
CAS
747403-13-0
化学式
C11H14N2O
mdl
——
分子量
190.245
InChiKey
UOMRXGPLZBRRSY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    343.3±32.0 °C(Predicted)
  • 密度:
    1.101±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    42
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    piperidin-4-yl(pyridin-3-yl)methanone三乙胺 作用下, 以 乙醇二氯甲烷乙酸乙酯 为溶剂, 反应 36.0h, 生成 (1-(3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(pyridin-3-yl)methanone oxalate
    参考文献:
    名称:
    Heteroaromatic and Aniline Derivatives of Piperidines As Potent Ligands for Vesicular Acetylcholine Transporter
    摘要:
    To identify suitable lipophilic compounds having high potency and selectivity for vesicular acetylcholine transporter (VAChT), a heteroaromatic ring or a phenyl group was introduced into the carbonyl-containing scaffold for VAChT ligands. Twenty new compounds with ALogD values between 0.53 and 3.2 were synthesized, and their in vitro binding affinities were assayed. Six of them (19a, 19e, 19g, 19k, and 24a-b) displayed high affinity for VAChT (K-i = 0.93-18 nM for racemates) and moderate to high selectivity for VAChT over sigma(1) and sigma(2) receptors (K-i = 44-4400-fold). These compounds have a methyl or a fluoro substitution that provides the position for incorporating PET radioisotopes C-11 or F-18. Compound (-)-[C-11]24b (K-i = 0.78 nM for VAChT, 1200-fold over sigma receptors) was successfully synthesized and evaluated in vivo in rats and nonhuman primates. The data revealed that (-)-[C-11]24b has highest binding in striatum and has favorable pharmacokinetics in the brain.
    DOI:
    10.1021/jm400664x
  • 作为产物:
    描述:
    1-Boc-4-[甲氧基(甲基)氨基甲酰]哌嗪三氟乙酸 、 lithium dibutyl(isopropyl)magnesate 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 6.0h, 生成 piperidin-4-yl(pyridin-3-yl)methanone
    参考文献:
    名称:
    Heteroaromatic and Aniline Derivatives of Piperidines As Potent Ligands for Vesicular Acetylcholine Transporter
    摘要:
    To identify suitable lipophilic compounds having high potency and selectivity for vesicular acetylcholine transporter (VAChT), a heteroaromatic ring or a phenyl group was introduced into the carbonyl-containing scaffold for VAChT ligands. Twenty new compounds with ALogD values between 0.53 and 3.2 were synthesized, and their in vitro binding affinities were assayed. Six of them (19a, 19e, 19g, 19k, and 24a-b) displayed high affinity for VAChT (K-i = 0.93-18 nM for racemates) and moderate to high selectivity for VAChT over sigma(1) and sigma(2) receptors (K-i = 44-4400-fold). These compounds have a methyl or a fluoro substitution that provides the position for incorporating PET radioisotopes C-11 or F-18. Compound (-)-[C-11]24b (K-i = 0.78 nM for VAChT, 1200-fold over sigma receptors) was successfully synthesized and evaluated in vivo in rats and nonhuman primates. The data revealed that (-)-[C-11]24b has highest binding in striatum and has favorable pharmacokinetics in the brain.
    DOI:
    10.1021/jm400664x
点击查看最新优质反应信息

文献信息

  • [EN] RADIOLABELED COMPOUNDS<br/>[FR] COMPOSÉS RADIOMARQUÉS
    申请人:TAKEDA PHARMACEUTICAL
    公开号:WO2015190613A1
    公开(公告)日:2015-12-17
    The present invention provides radiolabeled compounds useful as radiotracers for quantitative imaging of CH24H in mammals. The compound of the present invention is represented by the formula (I): wherein each symbol is as defined in the specification.
    本发明提供了用于哺乳动物中CH24H的定量成像的放射性示踪剂有用的放射性标记化合物。本发明的化合物由公式(I)表示:其中每个符号如说明书中所定义。
  • [EN] SUBSTITUTED QUINOXALINE DERIVATIVES<br/>[FR] DÉRIVÉS DE QUINOXALINE SUBSTITUÉS
    申请人:SELVITA S A
    公开号:WO2016180536A1
    公开(公告)日:2016-11-17
    The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    本发明涉及取代喹喔啉衍生物。这些化合物对预防和/或治疗包括过度增殖性疾病在内的多种医疗状况具有用处。
  • Compounds comprising 4-benzoylpiperidine as a Sigma-1-selective ligand
    申请人:Tu Zhude
    公开号:US20110311447A1
    公开(公告)日:2011-12-22
    Bipiperidinyl compounds and salts thereof are disclosed. The compounds include high affinity ligands for σ 1 receptors. Some compounds are also highly selective for σ 1 receptor compared to σ 2 receptor. Compounds can comprise radioisotopes, including 18 F or 11 C. Radiolabeled compounds can be used as probes for imaging distribution of σ 1 receptor in a subject such as a human using positron emission tomography (PET) scanning.
    双哌啶基化合物及其盐被披露。这些化合物包括对σ1受体具有高亲和力的配体。一些化合物相对于σ2受体也具有高选择性。化合物可以包含放射性同位素,包括18F或11C。放射标记的化合物可用作探针,用于通过正电子发射断层扫描(PET扫描)在受试者(如人类)中成像σ1受体的分布。
  • SULFAMIDE-METALLOPROTEASE INHIBITORS
    申请人:F. HOFFMANN-LA ROCHE AG
    公开号:EP0958287B1
    公开(公告)日:2002-09-11
  • RADIOLABELED COMPOUNDS
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP3152198A1
    公开(公告)日:2017-04-12
查看更多